glp-1 alcohol abuse What explains the success of drugs for treating and substance disorders? The success of GLP-1 (Glucagon-like peptide-1) drugs, such as semaglutide and liraglutide, in treating alcohol and substance use Effects of glucagon-like peptide-1 (GLP-1)

A personalized plan and professional support are key not just for weight loss but for your overall recovery and wellness journey

The six inhibitors are classified into three types based on their different binding to the active site of the DPP-4 enzyme

extended for analogs) GLP-3: Not well characterized Side Effects GLP-1: Nausea (common initially) Vomiting Diarrhea or constipation Reduced appetite Potential pancreatitis (rare) GLP-2: Generally well-tolerated Injection site reactions Abdominal pain or discomfort Nausea (less common than GLP-1) Fluid retention GLP-3: Unknown (no clinical use) Availability GLP-1: Widely available through prescription medications (semaglutide, liraglutide, etc.) and research peptides GLP-2: Available as teduglutide (Gattex/Revestive) by prescription

Those cardiovascular events usually occur in older adults

PMCID: PMC11822619.

J Clin Invest (2014) 124(6):245663